Merete JoergensenSenior Director, Clinical Transparency at Novo Nordisk
Senior Director in Clinical Transparency, has worked on Disclosure since 2004 and before that heading up Biostatistics. Holds an MSc in Statistics and an MBA in Management of Technology. More than 30 years of experience in Clinical Research in relation to drug development.
Member of the EFPIA Clinical Research Expert Group (CREG) and leading the Clinical Trials Transparency Pillar within CREG. Also engaged in the Clinical Disclosure Community, Drug Information Association.